Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                CVM Updates

CVM Updates Home
          Animal & Veterinary
          News & Events
          CVM Updates
          FDA Approves First Generic Cyclosporine Oral Solution for Cats for Treatment of Allergic DermatitisCVM Updates FDA Approves First Generic Cyclosporine Oral Solution for Cats for Treatment of Allergic Dermatitis
  
  	
    Share
    Post
    Linkedin

    Email
    PrintMarch 29, 2023

Today, the U.S. Food and Drug Administration approved Modulis for Cats, the first generic cyclosporine oral solution for cats. Modulis for Cats is indicated for the control of certain skin conditions resulting from a disease called feline allergic dermatitis.

Cats with feline allergic dermatitis may be intensely itchy and lick, chew and scratch at their skin and hair. As a result, affected cats can develop excoriations (due to the cat scratching itself), miliary dermatitis (a skin condition in cats that most commonly is due to allergic reaction), eosinophilic plaques (skin lesions), and self-induced alopecia (hair loss).

Modulis for Cats is an immunosuppressant drug that suppresses the allergic process that causes cats with this condition to be itchy. It contains the same active ingredient (cyclosporine) in the same concentration and dosage form as the approved brand name drug product, Atopica for Cats, which was first approved on August 8, 2011.

Modulis for Cats is intended for use in cats at least 6 months of age and at least 3 lbs (1.4 kg) in body weight. It is only available by prescription from a licensed veterinarian because professional veterinary expertise is needed to diagnose feline allergic dermatitis and determine whether Modulis for Cats is an appropriate treatment.

People handling, administering, or exposed to Modulis for Cats should take precautions to avoid accidentally ingesting the drug, such as not eating, drinking, smoking or using smokeless tobacco while handling it. Users should also wash hands after administration of Modulis for Cats. People with known hypersensitivity to cyclosporine should avoid contact with the product.

Modulis for Cats is supplied in 4.7, 15, and 30 mL glass amber bottles.

Modulis for Cats is sponsored by Provetica, LLC, based in Lenexa, Kansas.

For more information:

Freedom of Information Summary**Issued by FDA Center for Veterinary Medicine.
For questions, Contact CVM.**

                                                                                  Content current as of:
      03/29/2023CVM Updates
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop